CAS: 783355-60-2 - 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide

Formel: C₂₁H₂₃N₃O₅

InChl: InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25)

InChI Key: InChIKey=MAUCONCHVWBMHK-UHFFFAOYSA-N

SMILES: O=C(NO)C1=CC=C(OCCNC(=O)C=2OC=3C=CC=CC3C2CN(C)C)C=C1

Synonyme:

• 2-Benzofurancarboxamide, 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-
• 3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide
• Abexinostat
• Brd K12867552
• Cra 024781
• Cra 24781
• Pci 24781
• Thm-I 94

Abexinostat

CAS: 783355-60-2

PCI-24781 (Abexinostat (PCI24781)) is a new pan-HDAC inhibitor mainly targeting HDAC1 (Ki: 7 nM), also …

• Formel: C₂₁H₂₃N₃O₅
• Reinheit: 98.43%
• Farbe und Form: Solid
• Molekulargewicht: 397.42

CRA-02478

CAS: 783355-60-2

• Formel: C₂₁H₂₃N₃O₅
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 397.4244

PCI-24781

CAS: 783355-60-2

Applications PCI-24781 is a novel hydroxamic acid HDAC inhibitor (histone deacetylase inhibitor). PCI-24781 exerts cytotoxicity …

• Formel: C₂₁H₂₃N₃O₅
• Farbe und Form: Neat
• Molekulargewicht: 397.4244

PCI 24781

CAS: 783355-60-2

HDAC enzyme inhibitor; antineoplastic

• Formel: C₂₁H₂₃N₃O₅
• Reinheit: Min. 95%
• Molekulargewicht: 397.42 g/mol